Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04408586 · ClinicalTrials.gov registry record · Phase 4
Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
NCT04408586: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT04408586 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04408586, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
Study Summary
Researchers are assessing the effects of weight loss medication vs a placebo among participants provided with a wearable activity tracker, digital wellness devices and lifestyle recommendations.
Interventions
- DRUG Placebo
- DRUG Phentermine-Topiramate Extended Release
- OTHER Online support system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2020-06-03 |
| Est. Completion | 2022-10-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04408586
The ClinicalTrials.gov registry entry for NCT04408586 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04408586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04408586 about?
NCT04408586 is a clinical study titled "Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker". Researchers are assessing the effects of weight loss medication vs a placebo among participants provided with a wearable activity tracker, digital wellness devices and lifestyle recommendations.
What is the current status of trial NCT04408586?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2020-06-03. Estimated completion is 2022-10-11.
What interventions are being tested in trial NCT04408586?
The interventions under investigation include: Placebo (DRUG), Phentermine-Topiramate Extended Release (DRUG), Online support system (OTHER).
Who is sponsoring clinical trial NCT04408586?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.